{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:08Z","timestamp":1786119608378,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/inf.0b013e3181f728fd","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T06:50:50Z","timestamp":1284533450000},"page":"197-202","source":"Crossref","is-referenced-by-count":25,"title":["Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine"],"prefix":"10.1097","volume":"30","author":[{"given":"Ameneh","family":"Khatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Westcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaam","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llinos","family":"Rollinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Boutriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcisa","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Galaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"B20","DOI":"10.1016\/j.vaccine.2009.04.067","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales.","volume":"27","author":"Campbell","year":"2009","journal-title":"Vaccine"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.","volume":"24","author":"Snape","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence following serogroup C meningococcal conjugate immunization of UK primary school children in 1999 to 2000 and response to a booster.","volume":"15","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection and modeling predictions of the duration of herd immunity.","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.284.18.2334","article-title":"Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.","volume":"284","author":"Heath","year":"2000","journal-title":"JAMA"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(03)13172-8","article-title":"Antibody to Haemophilus influenzae type b after routine and catch-up vaccination.","volume":"361","author":"Trotter","year":"2003","journal-title":"Lancet"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e31813429fa","article-title":"A new combination Haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.","volume":"26","author":"Pace","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(85)92863-6","article-title":"Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide\/diphtheria toxoid conjugate vaccine.","volume":"1","author":"Eskola","year":"1985","journal-title":"Lancet"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2458-7-130","article-title":"Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.","volume":"7","author":"Caro","year":"2007","journal-title":"BMC Public Health"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.inf.0000076386.52719.b3","article-title":"Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.","volume":"22","author":"McVernon","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/adc.88.5.379","article-title":"Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.","volume":"88","author":"McVernon","year":"2003","journal-title":"Arch Dis Child"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.mop.0000193265.78506.7f","article-title":"Recent trends in meningococcal epidemiology and current vaccine recommendations.","volume":"18","author":"Baltimore","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3201\/eid1206.051297","article-title":"Social behavior and meningococcal carriage in British teenagers.","volume":"12","author":"MacLennan","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months.","volume":"29","author":"D\u00edez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies.","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"R31-4-20210202","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1586\/erv.09.88","article-title":"Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience.","volume":"8","author":"Hallander","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1016\/j.vaccine.2009.06.049","article-title":"Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.","volume":"27","author":"Kitchin","year":"2009","journal-title":"Vaccine"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.vaccine.2003.10.025","article-title":"Pentavac Study Group. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5\u20136-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.","volume":"22","author":"Mallet","year":"2004","journal-title":"Vaccine"},{"key":"R36-4-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006454-200206000-00011","article-title":"Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy.","volume":"21","author":"Carlsson","year":"2002","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e3181f728fd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:33:44Z","timestamp":1786041224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201103000-00004"}},"subtitle":["Follow-up of a Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181f728fd","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}